Owens & Minor (OMI) Expected to Announce Quarterly Earnings on Thursday

Owens & Minor (NYSE:OMI) will likely be posting its Q3 2025 results after the market closes on Thursday, October 30th. Analysts expect Owens & Minor to post earnings of $0.23 per share and revenue of $704.0630 million for the quarter. Owens & Minor has set its FY 2025 guidance at 1.020-1.070 EPS.Parties are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Thursday, October 30, 2025 at 5:00 PM ET.

Owens & Minor (NYSE:OMI) last posted its earnings results on Monday, August 11th. The company reported $0.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.01). The firm had revenue of $681.90 million during the quarter, compared to the consensus estimate of $2.73 billion. Owens & Minor had a negative net margin of 13.78% and a positive return on equity of 26.59%. The business’s revenue was up 3.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.36 EPS. On average, analysts expect Owens & Minor to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Owens & Minor Price Performance

Owens & Minor stock opened at $5.51 on Tuesday. The business’s fifty day moving average is $5.07 and its two-hundred day moving average is $6.53. The firm has a market cap of $425.21 million, a P/E ratio of -0.35 and a beta of 1.26. The company has a debt-to-equity ratio of 3.32, a quick ratio of 0.83 and a current ratio of 0.86. Owens & Minor has a 52 week low of $4.34 and a 52 week high of $15.54.

Insider Buying and Selling at Owens & Minor

In related news, major shareholder Coliseum Capital Management, L acquired 720,000 shares of the company’s stock in a transaction dated Tuesday, August 12th. The shares were bought at an average price of $5.15 per share, for a total transaction of $3,708,000.00. Following the purchase, the insider directly owned 12,282,955 shares in the company, valued at approximately $63,257,218.25. This trade represents a 6.23% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last quarter, insiders purchased 1,537,852 shares of company stock worth $8,099,544. 3.69% of the stock is owned by insiders.

Institutional Investors Weigh In On Owens & Minor

Several hedge funds have recently bought and sold shares of OMI. Paradigm Capital Management Inc. NY increased its holdings in Owens & Minor by 3,197.8% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 1,978,700 shares of the company’s stock valued at $18,006,000 after buying an additional 1,918,700 shares during the period. PDT Partners LLC bought a new position in shares of Owens & Minor in the 2nd quarter valued at $2,055,000. Goldman Sachs Group Inc. raised its holdings in shares of Owens & Minor by 43.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 576,799 shares of the company’s stock worth $5,208,000 after buying an additional 175,866 shares in the last quarter. Invesco Ltd. lifted its position in shares of Owens & Minor by 10.0% during the 2nd quarter. Invesco Ltd. now owns 1,888,548 shares of the company’s stock worth $17,186,000 after buying an additional 171,653 shares during the last quarter. Finally, Squarepoint Ops LLC boosted its stake in Owens & Minor by 283.8% in the second quarter. Squarepoint Ops LLC now owns 167,176 shares of the company’s stock valued at $1,521,000 after buying an additional 123,616 shares in the last quarter. 98.04% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

OMI has been the topic of several research reports. Robert W. Baird reduced their price objective on Owens & Minor from $10.00 to $7.00 and set an “outperform” rating on the stock in a report on Tuesday, August 12th. Weiss Ratings restated a “sell (e+)” rating on shares of Owens & Minor in a report on Wednesday, October 8th. Baird R W upgraded Owens & Minor from a “hold” rating to a “strong-buy” rating in a report on Friday, August 8th. UBS Group set a $7.00 target price on shares of Owens & Minor in a report on Wednesday, August 13th. Finally, Citigroup restated a “buy” rating and set a $7.00 price objective (down from $11.00) on shares of Owens & Minor in a report on Tuesday, August 12th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, two have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, Owens & Minor currently has a consensus rating of “Hold” and an average price target of $7.63.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.